Abstract
Atopic disease, including asthma, food allergies and atopic dermatitis, are on the rise. Concurrently, the use of non-steroidal anti-inflammatory drugs (NSAIDs) is also growing resulting in 30 billion American doses yearly. NSAIDs, which inhibit cyclooxygenase enzymes (COX) have been associated with worse allergic diseases and is thought to exacerbate allergic inflammation by shunting arachidonic acid metabolism towards leukotriene synthesis. We hypothesize that NSAIDs possess adjuvant properties and are sufficient to induce allergic sensitization, and thus may partially explain the exponential increase in the prevalence of allergic diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have